These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3490975)

  • 21. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
    König U; Müller U; Binswanger U
    Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
    Grüneberg RN; Emmerson AM
    Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative in vitro activity of cefetamet (RO 15-8074).
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Aug; 6(4):496-7. PubMed ID: 3478193
    [No Abstract]   [Full Text] [Related]  

  • 26. In-vitro activity of cefetamet (Ro 15-8074) compared with other oral agents.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Antimicrob Chemother; 1989 Oct; 24(4):539-46. PubMed ID: 2613603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of bactericidal activity of trimethoprim-sulfamethoxazole against some strains of Haemophilus influenzae type B.
    Gustafson TL; Kelley RA; Hutcheson RH; Schaffner W; Sell SH; Yogev R; Moxon R
    Pediatr Infect Dis; 1984; 3(6):597-8. PubMed ID: 6334847
    [No Abstract]   [Full Text] [Related]  

  • 28. Discrepancies between in vitro activity of and in vivo response to antimicrobial agents.
    Washington JA
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):25-31. PubMed ID: 6423340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
    Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
    Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P; Hohl P; Then RL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):731-6. PubMed ID: 310281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
    Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
    Hohl P; Lüthy-Hottenstein J; Zollinger-Iten J; Altwegg M
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1605-8. PubMed ID: 2121095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
    Yogev R; Moxon ER
    J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The taxonomy and antimicrobial susceptibility of Haemophilus species in clinical specimens.
    Yogev R
    Am J Clin Pathol; 1979 Jul; 72(1):133-4. PubMed ID: 313150
    [No Abstract]   [Full Text] [Related]  

  • 37. Sensitivity of Haemophilus influenzae to antibiotics.
    Williams JD; Andrews J
    Br Med J; 1974 Jan; 1(5899):134-7. PubMed ID: 4544225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-trimoxazole resistance in Jamaica.
    Macfarlane DE
    Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
    [No Abstract]   [Full Text] [Related]  

  • 39. Resistance of Haemophilus influenzae to trimethoprim.
    May JR; Davies J
    Br Med J; 1972 Aug; 3(5823):376-7. PubMed ID: 4538444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.